EPISODE · Jan 23, 2025 · 0 MIN
Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase
from Migraine Minute News Update
According to a study published in Neurology, when compared to placebo, this gepant led to significantly greater ability to function normally and a greater reduction in activity limitation when taken during the prodrome phase of an attack. Molly O'Brien has the details in this Migraine Minute News Update. Read More: https://bit.ly/3BY2J9d
NOW PLAYING
Ubrogepant Reduced Migraine-Related Limitations When Taken During the Prodrome Phase
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m